Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Changing the peptide specificity of a human T-cell receptor by directed evolution.

Smith SN, Wang Y, Baylon JL, Singh NK, Baker BM, Tajkhorshid E, Kranz DM.

Nat Commun. 2014 Nov 7;5:5223. doi: 10.1038/ncomms6223.

2.

How T cell receptors interact with peptide-MHCs: a multiple steered molecular dynamics study.

Cuendet MA, Zoete V, Michielin O.

Proteins. 2011 Nov;79(11):3007-24. doi: 10.1002/prot.23104. Epub 2011 Aug 30.

PMID:
21989928
3.
4.

T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility.

Borbulevych OY, Piepenbrink KH, Gloor BE, Scott DR, Sommese RF, Cole DK, Sewell AK, Baker BM.

Immunity. 2009 Dec 18;31(6):885-96. doi: 10.1016/j.immuni.2009.11.003.

5.

A general and efficient approach for NMR studies of peptide dynamics in class I MHC peptide binding grooves.

Insaidoo FK, Zajicek J, Baker BM.

Biochemistry. 2009 Oct 20;48(41):9708-10. doi: 10.1021/bi9008787.

6.

Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex.

Cuendet MA, Michielin O.

Biophys J. 2008 Oct;95(8):3575-90. doi: 10.1529/biophysj.108.131383. Epub 2008 Jul 11.

7.

T cell receptor binding transition states and recognition of peptide/MHC.

Davis-Harrison RL, Insaidoo FK, Baker BM.

Biochemistry. 2007 Feb 20;46(7):1840-50. Epub 2007 Jan 24.

PMID:
17249694
8.

The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.

Khan AR, Baker BM, Ghosh P, Biddison WE, Wiley DC.

J Immunol. 2000 Jun 15;164(12):6398-405.

10.
11.

Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.

Zweerink HJ, Gammon MC, Utz U, Sauma SY, Harrer T, Hawkins JC, Johnson RP, Sirotina A, Hermes JD, Walker BD, et al.

J Immunol. 1993 Mar 1;150(5):1763-71.

PMID:
7679694
12.

Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.

Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H, et al.

J Virol. 1992 May;66(5):2928-33.

Supplemental Content

Loading ...
Support Center